[1]吴怡琪,卢 文.皮肤AGEs荧光检测对糖尿病肾病的临床意义[J].医学信息,2019,32(06):101-104.[doi:10.3969/j.issn.1006-1959.2019.06.031]
　WU Yi-qi,LU Wen.Clinical Significance of Skin AGEs Fluorescence Detection in Diabetic Kidney Disease[J].Journal of Medical Information,2019,32(06):101-104.[doi:10.3969/j.issn.1006-1959.2019.06.031]
点击复制

皮肤AGEs荧光检测对糖尿病肾病的临床意义()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年06期
页码:
101-104
栏目:
论著
出版日期:
2019-03-15

文章信息/Info

Title:
Clinical Significance of Skin AGEs Fluorescence Detection in Diabetic Kidney Disease
文章编号:
1006-1959（2019）06-0101-04
作者:
吴怡琪; 卢 文
（安徽医科大学第一附属医院肾脏内科，安徽 合肥 230022）
Author(s):
WU Yi-qi; LU Wen
(Department of Nephrology,the First Affiliated Hospital of Anhui Medical University, Hefei 230022, Anhui,China)
关键词:
糖尿病肾病; 糖尿病; 糖基化终产物; 荧光光谱法; 皮肤
Keywords:
Diabetickidney disease; Diabetes; Glycation end products; Fluorescence spectroscopy; Skin
分类号:
R587.2
DOI:
10.3969/j.issn.1006-1959.2019.06.031
文献标志码:
A
摘要:
目的 探讨皮肤AGEs荧光检测对糖尿病肾病的早期诊断价值及与糖尿病肾病分期相关性的临床意义。方法 将我院住院的122例糖尿病患者按尿白蛋白/肌酐比值，眼底检查及CKD分期分为单纯糖尿病组（DM0组）42例、糖尿病肾病eGFR≥45 ml/（min·1.73 m2）组（DKD1组）49例和糖尿病肾病eGFR＜45 ml/（min/1.73·m2）组（DKD2组）31例，选取同期行肾穿刺肾功能正常的非糖尿病患者51例为对照组（NC组），分别检测各组皮肤AGEs、血白蛋白、尿微量白蛋白等指标。结果 ①糖尿病患者的皮肤AGEs、SBP、SCr、TG、TC均高于对照组，ALB、HB低于对照组，差异均有统计学意义（P＜0.05）；②与DMO组比较，DKD1组和DKD2组的SBP、肌酐、UA、24hUP、尿微量白蛋白、皮肤AGEs水平均升高，且DKD2组高于DKD1组，差异有统计学意义（P＜0.05)；而TP、ALB、HB水平均降低，且DKD2组低于DKD1组，差异有统计学意义（P＜0.05）；③糖尿病患者皮肤AGEs水平与尿微量白蛋白水平呈正相关（r=0.484，P＜0.05）。④皮肤AGEs是糖尿病肾病相关的危险因素[OR=1.113，95%CI（1.055，1.174）]。⑤ROC曲线分析显示皮肤AGEs检测糖尿病肾病的敏感性为68.75%，特异性为71.43%。结论 AGEs可能参与糖尿病肾病发生发展，荧光检测皮肤AGEs可用于早期筛查DKD并且评估其病变程度。
Abstract:
Objective To investigate the value of skin AGEs fluorescence detection in early diagnosis of diabetic kidney disease and its clinical significance in relation to staging of diabetic kidney disease.Methods The 122 patients with diabetes admitted to our hospital were divided into urinary albumin/creatinine ratio, fundus examination and CKD staging into 42 patients with diabetes alone (DM0 group) and diabetic kidney disease with eGFR ≥ 45 ml/(min·1.73 m2) group (DKD1). Group of 49 patients with diabetic kidney disease eGFR<45 ml/(min/1.73·m2) group (DKD2 group) 31 cases, 51 cases of non-diabetic patients with normal renal renal function were selected as control group (NC group), respectively the indicators of skin AGEs, serum albumin, and urine microalbumin were measured. Results ①The skin AGEs, SBP, SCr, TG and TC of diabetic patients were higher than the control group, and the ALB and HB were lower than the control group, the difference was statistically significant (P<0.05). ②Compared with DMO group, SBP, creatinine, UA, 24hUP, urinary albumin and AGEs of DKD1 group and DKD2 group were increased, and DKD2 group was higher than DKD1 group, the difference was statistically significant (P<0.05). The TP, ALB, and HB levels were lower, and the DKD2 group was lower than the DKD1 group,the difference was statistically significant (P<0.05).③The level of skin AGEs in diabetic patients was positively correlated with urinary microalbumin (r=0.484, P<0.05).④Skin AGEs are risk factors associated with diabetic kidney disease [OR=1.113, 95% CI (1.055, 1.174)].⑤ROC curve analysis showed that the sensitivity of skin AGEs to detect diabetic kidney disease was 68.75% and the specificity was 71.43%. Conclusion AGEs may be involved in the development of diabetic kidney disease.Fluorescence detection of skin AGEs can be used to screen DKD early and assess the extent of the disease.

参考文献/References:

[1]Sternberg M,M'Bemba J,Urios P,et al.Skin collagen pentosidine and fluorescence in diabetes were predictors of retinopathy progression and creatininemia increase already 6 years after punch-biopsy[J].Clinical Biochemistry,2016,49(3):225-231. [2]Vélayoudom-Céphise FL,Rajaobelina K,Helmer C,et al.Skin autofluorescence predicts cardio-renal outcome in type 1 diabetes: a longitudinal study[J].Cardiovascular Diabetology,2016,15(1):127. [3]中华医学会糖尿病学分会微血管并发症学组.糖尿病肾病防治专家共识（2014年版）[J].中国糖尿病杂志,2014,6(11):792-801. [4]全国eGFR课题协作组.MDRD方程在我国慢性肾脏病患者中的改良和评估[J].中华肾脏病杂志,2006,22(10):589-595. [5]McNair E,Qureshi M,Prasad K,et al.Atherosclerosis and the Hypercholesterolemic AGE-RAGE Axis[J].International Journal of Angiology,2016,25(2):110-116. [6]张斌,刘晓志,周敬华,等.抗体药物糖化检测方法及其生物学功能研究进展[J].生物技术进展,2018,8(1):28-33. [7]Genevieve M,Vivot A,Gonzalez C,et al.Skin autofluorescence is associated with past glycaemic control and complications in type 1 diabetes mellitus[J]. Diabetes & Metabolism,2013,39(4):349-354. [8]Kumar PA,Chitra PS,Reddy GB.Advanced glycation end products mediated cellular and molecular events in the pathology of diabetic nephropathy[J].Biomol Concepts,2016,7(5-6):293-309. [9]Beisswenger PJ,Howell SK,Russell GB,et al.Early Progression of Diabetic Nephropathy Correlates With Methylglyoxal-Derived Advanced Glycation End Products[J].Diabetes Care,2013,36(10):3234-3239. [10]程璐,付平.糖尿病肾病的诊断与鉴别诊断——肾活检在糖尿病肾病诊断中的应用[J].中国实用内科杂志,2017,37(3):192-194. [11]Gawandi S,Gangawane S,Chakrabarti A,et al.A Study of Microalbuminuria (MAU) and Advanced Glycation End Products (AGEs) Levels in Diabetic and Hypertensive Subjects[J].Indian Journal of Clinical Biochemistry,2018,33(Suppl 1):1-5.

相似文献/References:

[1]张西园.糖尿病与结直肠癌患者预后相关研究进展[J].医学信息,2018,31(01):55.[doi:10.3969/j.issn.1006-1959.2018.01.020]
　ZHANG Xi-yuan.Research Progress in the Relationship between Diabetes and the Prognosis of Colorectal Cancer[J].Journal of Medical Information,2018,31(06):55.[doi:10.3969/j.issn.1006-1959.2018.01.020]
[2]耿金萍.综合护理对甲状腺良性肿瘤并糖尿病患者手术效果的影响分析[J].医学信息,2018,31(01):163.[doi:10.3969/j.issn.1006-1959.2018.01.064]
　GENG Jin-ping.Analysis of the Effect of Comprehensive Nursing on the Surgical Effect of Thyroid Benign Tumor and Diabetic Patients[J].Journal of Medical Information,2018,31(06):163.[doi:10.3969/j.issn.1006-1959.2018.01.064]
[3]李雯婷,谈世华,余江明,等.踝肱指数检测在住院糖尿病患者中的重复性研究[J].医学信息,2018,31(03):159.[doi:10.3969/j.issn.1006-1959.2018.03.058]
　LI Wen-ting,TAN Shi-hua,YU Jiang-ming,et al.Study on Reproducibility of Ankle-brachial Index in Inpatients with Diabetes Mellitus[J].Journal of Medical Information,2018,31(06):159.[doi:10.3969/j.issn.1006-1959.2018.03.058]
[4]刘 静.冠状动脉粥样硬化性心脏病合并糖尿病的血脂检验结果分析[J].医学信息,2018,31(04):154.[doi:10.3969/j.issn.1006-1959.2018.04.057]
　LIU Jing.Analysis of Blood Lipid Test Results in Coronary Atherosclerotic Heart Disease Complicated with Diabetes Mellitus[J].Journal of Medical Information,2018,31(06):154.[doi:10.3969/j.issn.1006-1959.2018.04.057]
[5]谢勇丽,苏晓清,张雅薇.糖尿病痛性周围神经病变患者情绪调查分析[J].医学信息,2018,31(05):14.[doi:10.3969/j.issn.1006-1959.2018.05.005]
　XIE Yong-li,SU Xiao-qing,ZHANG Ya-wei.Investigation and Analysis of Mood in Patients with Diabetic Peripheral Neuropathy[J].Journal of Medical Information,2018,31(06):14.[doi:10.3969/j.issn.1006-1959.2018.05.005]
[6]陈淑雯.肾衰宁联合科素亚治疗早期糖尿病肾病的临床观察[J].医学信息,2018,31(05):20.[doi:10.3969/j.issn.1006-1959.2018.05.007]
　CHEN Shu-wen.Clinical Observation on Early Diabetic Nephropathy Treated by Shenshuaining Combined with Kosu[J].Journal of Medical Information,2018,31(06):20.[doi:10.3969/j.issn.1006-1959.2018.05.007]
[7]张雅薇,朱明慧.首发为动眼神经麻痹的糖尿病合并动眼神经麻痹误诊为痛性眼肌麻痹1例分析[J].医学信息,2018,31(05):23.[doi:10.3969/j.issn.1006-1959.2018.05.008]
　ZHANG Ya-wei,ZHU Ming-hui.An Analysis of a Case of Diabetes Mellitus with Oculomotor Nerve Palsy Misdiagnosed as Painful Ophthalmoplegia[J].Journal of Medical Information,2018,31(06):23.[doi:10.3969/j.issn.1006-1959.2018.05.008]
[8]张宇宁.黄酮类化合物治疗糖尿病及其并发症的研究[J].医学信息,2018,31(05):50.[doi:10.3969/j.issn.1006-1959.2018.05.018]
　ZHANG Yu-ning.Study on Flavonoids in the Treatment of Diabetes Mellitus and its Complications[J].Journal of Medical Information,2018,31(06):50.[doi:10.3969/j.issn.1006-1959.2018.05.018]
[9]柳 梅.头孢哌酮钠舒巴坦钠治疗糖尿病并发尿路感染的 临床效果观察[J].医学信息,2018,31(07):139.[doi:10.3969/j.issn.1006-1959.2018.07.047]
　LIU Mei.Clinical Efficacy of Cefoperazone Sodium and Sulbactam Sodium in Treatment of Diabetes Complicated with Urinary Tract Infection[J].Journal of Medical Information,2018,31(06):139.[doi:10.3969/j.issn.1006-1959.2018.07.047]
[10]吕桂英.影响糖尿病患者药物治疗依从性相关因素临床分析[J].医学信息,2018,31(08):109.[doi:10.3969/j.issn.1006-1959.2018.08.036]
　LV Gui-ying.Clinical Analysis of Factors Related to Compliance with Drug Therapy in Patients with Diabetes Mellitus[J].Journal of Medical Information,2018,31(06):109.[doi:10.3969/j.issn.1006-1959.2018.08.036]
[11]王 静,郭宏敏.肝型脂肪酸结合蛋白在糖尿病中的研究[J].医学信息,2019,32(18):18.[doi:10.3969/j.issn.1006-1959.2019.18.007]
　WANG Jing,GUO Hong-min.Study on Hepatic Fatty Acid Binding Protein in Diabetes[J].Journal of Medical Information,2019,32(06):18.[doi:10.3969/j.issn.1006-1959.2019.18.007]
[12]党佳蓉,党琳慧,郭煦妍,等.糖尿病肾病的发病机制研究[J].医学信息,2022,35(17):161.[doi:10.3969/j.issn.1006-1959.2022.17.044]
　DANG Jia-rong,DANG Lin-hui,GUO Xu-yan,et al.Study on Pathogenesis of Diabetic Nephropathy[J].Journal of Medical Information,2022,35(06):161.[doi:10.3969/j.issn.1006-1959.2022.17.044]

更新日期/Last Update: 2019-03-15